BIOCRYST PHARMACEUTICALS INC

BCRX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
259
SEC Filings

Business Summary

PART I Our Business We are a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases, driven by our deep commitment to improving the lives of people living with these conditions. We have built a robust commercial infrastructure to support the successful commercialization of ORLADEYO, an oral, once-daily therapy discovered and developed internally for the prevention of HAE attacks. Our business strategy includes leve...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBCRXdiscussed_in_filing Artificial Intelligence
topic_mentionBCRXdiscussed_in_filing Cybersecurity
topic_mentionBCRXdiscussed_in_filing Trusted Computing
topic_mentionBCRXdiscussed_in_filing Blockchain & Crypto
topic_mentionBCRXdiscussed_in_filing Regulation
topic_mentionBCRXdiscussed_in_filing Healthcare & Bio
topic_mentionBCRXdiscussed_in_filing Platform & Ecosystem
topic_mentionBCRXdiscussed_in_filing Sovereign & Government
topic_mentionBCRXdiscussed_in_filing Artificial Intelligence
topic_mentionBCRXdiscussed_in_filing Cybersecurity
topic_mentionBCRXdiscussed_in_filing Trusted Computing
topic_mentionBCRXdiscussed_in_filing Blockchain & Crypto
topic_mentionBCRXdiscussed_in_filing Regulation
topic_mentionBCRXdiscussed_in_filing Healthcare & Bio
topic_mentionBCRXdiscussed_in_filing Platform & Ecosystem
topic_mentionBCRXdiscussed_in_filing Sovereign & Government
topic_mentionBCRXdiscussed_in_filing Artificial Intelligence
topic_mentionBCRXdiscussed_in_filing Cybersecurity
topic_mentionBCRXdiscussed_in_filing Trusted Computing
topic_mentionBCRXdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012240EDGAR87K words
2025-02-252024-12-310001628280-25-007715EDGAR—
2024-02-272023-12-310001628280-24-007205EDGAR—
2023-02-272022-12-310001628280-23-005259EDGAR—
2022-02-282021-12-310001171843-22-001460EDGAR—
2021-03-012020-12-310001171843-21-001411EDGAR—
2020-03-132019-12-310001171843-20-001710EDGAR—
2019-03-142018-12-310001171843-19-001727EDGAR—
2018-03-122017-12-310001171843-18-001855EDGAR—
2017-02-272016-12-310001171843-17-001159EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001628280-25-048785EDGAR61K words
2025-08-052025-06-300001628280-25-037795EDGAR—
2025-05-062025-03-310001628280-25-022658EDGAR—
2024-11-052024-09-300001628280-24-045364EDGAR—
2024-08-062024-06-300001628280-24-035170EDGAR—
2024-05-072024-03-310001628280-24-021069EDGAR—
2023-11-082023-09-300001628280-23-037847EDGAR—
2023-08-072023-06-300001628280-23-027820EDGAR—
2023-05-082023-03-310001628280-23-016458EDGAR—
2022-11-042022-09-300001628280-22-028463EDGAR—
2022-08-052022-06-300001628280-22-021373EDGAR—
2022-05-092022-03-310001171843-22-003423EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001171843-26-001119EDGAR5K words
2026-01-230001140361-26-002200EDGAR—
2026-01-120001171843-26-000213EDGAR—
2026-01-090001171843-26-000154EDGAR—
2025-12-120001171843-25-007909EDGAR—
2025-12-110001171843-25-007878EDGAR—
2025-12-030001140361-25-044110EDGAR—
2025-11-030001171843-25-006881EDGAR—
2025-10-140001140361-25-038031EDGAR—
2025-10-010001140361-25-036875EDGAR—

259 total filings indexed. 227 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0000882796
TickerBCRX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f11c9d2d785623ab4b03a74c1569b1382160898a27be8081303cf493c1386e10
parent: b5c962fbf91e2f66d0d67adc46bd6e0ace609eb4aa8bcc88f95661e1fa25daf1
content hash: 8630198aadf07cfb72e819fb0e9f7135ffdacac973c19f1fe2e31e2774b6fade
signed: 2026-04-13T04:43:54.439Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf